» Articles » PMID: 36839688

Design and Characterization of Lipid-Surfactant-Based Systems for Enhancing Topical Anti-Inflammatory Activity of Ursolic Acid

Abstract

Skin inflammation is a symptom of many skin diseases, such as eczema, psoriasis, and dermatitis, which cause rashes, redness, heat, or blistering. The use of natural products with anti-inflammatory properties has gained importance in treating these symptoms. Ursolic acid (UA), a promising natural compound that is used to treat skin diseases, exhibits low aqueous solubility, resulting in poor absorption and low bioavailability. Designing topical formulations focuses on providing adequate delivery via application to the skin surface. The aim of this study was to formulate and characterize lipid-surfactant-based systems for the delivery of UA. Microemulsions and liquid crystalline systems (LCs) were characterized by polarized light microscopy (PLM), rheology techniques, and textural and bioadhesive assays. PLM supported the self-assembly of these systems and elucidated their formation. Rheologic examination revealed pseudoplastic and thixotropic behavior appropriate, and assays confirmed the ability of these formulations to adhere to the skin. In vivo studies were performed, and inflammation induced by croton oil was assessed for response to microemulsions and LCs. UA anti-inflammatory activities of ~60% and 50% were demonstrated by two microemulsions and 40% and 35% by two LCs, respectively. These data support the continued development of colloidal systems to deliver UA to ameliorate skin inflammation.

Citing Articles

Ursolic Acid Formulations Effectively Induce Apoptosis and Limit Inflammation in the Psoriasis Models In Vitro.

Bielecka E, Zubrzycka N, Marzec K, Maksylewicz A, Sochalska M, Kulawik-Pioro A Biomedicines. 2024; 12(4).

PMID: 38672088 PMC: 11048670. DOI: 10.3390/biomedicines12040732.


Development and Characterization of New Miconazole-Based Microemulsions for Buccal Delivery by Implementing a Full Factorial Design Modeling.

Talianu M, Dinu-Pirvu C, Ghica M, Anuta V, Prisada R, Popa L Pharmaceutics. 2024; 16(2).

PMID: 38399325 PMC: 10893023. DOI: 10.3390/pharmaceutics16020271.


From Plants to Wound Dressing and Transdermal Delivery of Bioactive Compounds.

Isopencu G, Covaliu-Mierla C, Deleanu I Plants (Basel). 2023; 12(14).

PMID: 37514275 PMC: 10386126. DOI: 10.3390/plants12142661.


Topical Microemulsions: Skin Irritation Potential and Anti-Inflammatory Effects of Herbal Substances.

Leanpolchareanchai J, Teeranachaideekul V Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513911 PMC: 10384732. DOI: 10.3390/ph16070999.

References
1.
Torin Huzil J, Sivaloganathan S, Kohandel M, Foldvari M . Drug delivery through the skin: molecular simulations of barrier lipids to design more effective noninvasive dermal and transdermal delivery systems for small molecules, biologics, and cosmetics. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011; 3(5):449-462. DOI: 10.1002/wnan.147. View

2.
Rigon C, Marchiori M, da Silva Jardim F, Pegoraro N, Chaves P, Velho M . Hydrogel containing silibinin nanocapsules presents effective anti-inflammatory action in a model of irritant contact dermatitis in mice. Eur J Pharm Sci. 2019; 137:104969. DOI: 10.1016/j.ejps.2019.104969. View

3.
Carvalho F, Campos M, Peccinini R, Gremiao M . Nasal administration of liquid crystal precursor mucoadhesive vehicle as an alternative antiretroviral therapy. Eur J Pharm Biopharm. 2012; 84(1):219-27. DOI: 10.1016/j.ejpb.2012.11.021. View

4.
Shah J, Sadhale Y, Chilukuri D . Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev. 2001; 47(2-3):229-50. DOI: 10.1016/s0169-409x(01)00108-9. View

5.
da Silva J, de Souza Ferreira S, Reis A, Cook M, Bruschi M . Assessing Mucoadhesion in Polymer Gels: The Effect of Method Type and Instrument Variables. Polymers (Basel). 2019; 10(3). PMC: 6415125. DOI: 10.3390/polym10030254. View